Cardiovascular System Registration Assessment Study Guide (Second Edition)

The 50-Page High-Yield Cardiovascular System Digital Registration Assessment Study Guide (Second Edition) includes: 
 
Arrhythmias
Stroke Prevention
Antiarrhythmic drugs classification
Amiodarone
Cardiac Glycosides
Bleeding Disorders
Thromboembolism
Stroke
Oral Anticoagulants - Warfarin
Antiplatelet drugs - Aspirin
Antiplatelet Drugs - Clopidogrel
Antiplatelet Drugs - Dipyridamole
Anti Thrombotic Drugs
MHRA/CHM Advice For DOACs
Heparins
Hypertension
Treatment of Hypertension
Hypertension in pregnancy
Antihypertensive Drugs
Angiotensin-Converting Enzyme Inhibitors
Angiotensin Receptor Converting Inhibitors
Beta-blockers
Calcium Channel Blockers
Cardiovascular risk assessment and prevention
Heart Failure
Treatment of HF with reduced ejection fraction
Hyperlipidaemia
Statins
Stable Angina
Fibrinolytic drugs
Nitrates
Unstable Angina and Non-ST-Segment Elevation
(NSTEMI)
ST-Segment Elevation Myocardial Infarction
Oedema
Thiazide like diuretic
Hydrochlorothiazide
Loop diuretics
Potassium Sparing diuretics
Aldosterone Antagonists
Vascular Disease
 
The cardiovascular system study guide is intended to provide high-yield notes in preparation for the GPhC registration assessment. The guide has been produced in accordance with the latest British National Formulary (BNF) 82.
 
Disclaimer: These notes are not meant to replace your lecture/study notes but are instead supplementary resources to aid in studying. While all attempts were made to ensure validity and accuracy, there is no guarantee of validity or accuracy. The purchaser of this guide assumes all responsibility for the use of this material. The author does not assume any responsibility or liability whatsoever on behalf of any purchaser or reader of these guides.
 
No refunds due to the PDF nature of these notes